{"ModuleTitle": "Company Description", "CompanyName": "Incyte Corporation", "Symbol": "INCY", "Address": "1801 AUGUSTINE CUT-OFF, WILMINGTON, Delaware, 19803, United States of America", "Phone": "3024986700", "Industry": "Biotechnology: Commercial Physical & Biological Resarch", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Incyte is a biopharmaceutical company focused on the discovery, development and\r\ncommercialization of proprietary therapeutics. Our global headquarters is\r\nlocated in Wilmington, Delaware. We conduct our European clinical development\r\noperations from our offices in Geneva, Switzerland, and Lausanne, Switzerland;\r\nour Japanese office is in Tokyo.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2019%2f02%2f14%2f0001558370-19-000682.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Christiana Stamoulis", "title": "Chief Financial Officer & Executive Vice President"}, {"name": "Dashyant Dhanak", "title": "Chief Scientific Officer & Executive VP"}, {"name": "HervT Hoppenot", "title": "Chairman, President & Chief Executive Officer"}, {"name": "Steven H. Stein", "title": "Chief Medical Officer & Executive Vice President"}], "Number_of_employees": [], "Subsidiaries": ["NO INFO"]}